A recent report from Oppenheimer says Dupont DD has a solid cyclical portfolio, partly offset by a large pension/OPEB deficit and potential M&A risk. It appears relatively undervalued. Recovery is aided by strong earnings, but DD also strengthened its hand with $1.1B in '09 fixed cost reductions (another $400M in '10E, target '12E 39% fixed cost/revenue) and clear market share gains in Ag. Long term, we believe DD needs to develop a "killer app."
DuPont closed Wednesday at $44.62
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in